Genetic Markers for Prediction of Normal Tissue Toxicity After Radiotherapy

Seminars in Radiation Oncology

Volumn 18, Issue 2, 2008, Pages 126-135

  Alsner, Jan ^a   Andreassen, Christian Nicolaj ^a   Overgaard, Jens ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; DOSE RESPONSE; FIBROBLAST; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC MARKER; GENETIC VARIABILITY; GENOME; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION HAZARD; RADIATION INJURY; RADIATION RESPONSE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME; TREATMENT RESPONSE;

GENETIC MARKERS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; RADIATION GENETICS; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY; SUBCUTANEOUS TISSUE;

EID: 39749142193     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semradonc.2007.10.004     Document Type: Article

References (94)

1. Andreassen C.N., Alsner J., and Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis-Where and how to look for it?. Radiother Oncol 64 (2002) 131-140
2. Fernet M., and Hall J. Genetic biomarkers of therapeutic radiation sensitivity. DNA Repair (Amst) 3 (2004) 1237-1243
3. Andreassen C.N. Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?. Acta Oncol 44 (2005) 801-815
4. West C.M., Elliott R.M., and Burnet N.G. The genomics revolution and radiotherapy. Clin Oncol (R Coll Radiol) 19 (2007) 470-480
5. Lander E.S., Linton L.M., Birren B., et al. Initial sequencing and analysis of the human genome. Nature 409 (2001) 860-921
6. Venter J.C., Adams M.D., Myers E.W., et al. The sequence of the human genome. Science 291 (2001) 1304-1351
7. International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2005) 1299-1320
8. Liu H., Prugnolle F., Manica A., et al. A geographically explicit genetic model of worldwide human-settlement history. Am J Hum Genet 79 (2006) 230-237
9. Manica A., Amos W., Balloux F., et al. The effect of ancient population bottlenecks on human phenotypic variation. Nature 448 (2007) 346-348
10. Hirschhorn J.N., and Daly M.J. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6 (2005) 95-108
11. Li J., Zhou Y., and Elston R.C. Haplotype-based quantitative trait mapping using a clustering algorithm. BMC Bioinformatics 7 (2006) 258
12. Satagopan J.M., Verbel D.A., Venkatraman E.S., et al. Two-stage designs for gene-disease association studies. Biometrics 58 (2002) 163-170
13. Easton D.F., Pooley K.A., Dunning A.M., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447 (2007) 1087-1093
14. Cox A., Dunning A.M., Garcia-Closas M., et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39 (2007) 352-358
15. The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
16. Parkes M., Barrett J.C., Prescott N.J., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 39 (2007) 830-832
17. Todd J.A., Walker N.M., Cooper J.D., et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39 (2007) 857-864
18. Zeggini E., Weedon M.N., Lindgren C.M., et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316 (2007) 1336-1341
19. Frayling T.M., Timpson N.J., Weedon M.N., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316 (2007) 889-894
20. Saxena R., Voight B.F., Lyssenko V., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 (2007) 1331-1336
21. Chanock S.J., Manolio T., Boehnke M., et al. Replicating genotype-phenotype associations. Nature 447 (2007) 655-660
22. Marchini J., Howie B., Myers S., et al. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39 (2007) 906-913
23. ENCODE Project Consortium. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 306 (2004) 636-640
24. ENCODE Project Consortium. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447 (2007) 799-816
25. Rogers P.B., Plowman P.N., Harris S.J., et al. Four radiation hypersensitivity cases and their implications for clinical radiotherapy. Radiother Oncol 57 (2000) 143-154
26. Bentzen S.M., and Overgaard M. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol 20 (1991) 159-165
27. Bentzen S.M., Overgaard M., and Overgaard J. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. Eur J Cancer 29A (1993) 1373-1376
28. Andreassen C.N., Alsner J., Overgaard J., et al. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol 75 (2005) 18-21
29. Andreassen C.N., Alsner J., Overgaard M., et al. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 69 (2003) 127-135
30. Hölscher T., Bentzen S.M., and Baumann M. Influence of connective tissue diseases on the expression of radiation side effects: A systematic review. Radiother Oncol 78 (2006) 123-130
31. Overgaard M., Bentzen S.M., Christensen J.J., et al. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy irradiation. Radiother Oncol 9 (1987) 1-11
32. Bentzen S.M., Overgaard M., Thames H.D., et al. Early and late normal-tissue injury after postmastectomy radiotherapy alone or combined with chemotherapy. Int J Radiat Biol 56 (1989) 711-715
33. Andreassen C.N., Alsner J., Overgaard M., et al. Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1. SOD2, XRCC1, XRCC3, APEX and ATM- a study based on DNA from formalin fixed paraffin embedded tissue samples. Int J Radiat Biol 82 (2006) 577-586
34. Cesaretti J.A., Stock R.G., Atencio D.P., et al. A genetically determined dose-volume histogram predicts for rectal bleeding among patients treated with prostate brachytherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1410-1406
35. Brem R., Cox D.G., Chapot B., et al. The XRCC1-77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Carcinogenesis 27 (2006) 2469-2474
36. Syrris P., Carter N.D., Metcalfe J.C., et al. Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond) 95 (1998) 659-667
37. Awad M.R., El-Gamel A., Hasleton P., et al. Genotypic variation in the transforming growth factor-beta1 gene: Association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66 (1998) 1014-1020
38. Grainger D.J., Heathcote K., Chiano M., et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8 (1999) 93-97
39. Hinke V., Seck T., Clanget C., et al. Association of transforming growth factor-beta1 (TGFbeta1) T29 -> C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta1 in a population-based sample of postmenopausal german women. Calcif Tissue Int 69 (2001) 315-320
40. Grainger D.J., and Metcalfe J.C. Tamoxifen: teaching an old drug new tricks?. Nat Med 2 (1996) 381-385
41. Hoffmann S.C., Stanley E.M., Cox E.D., et al. Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2 (2002) 560-567
42. Bentzen S.M., Thames H.D., and Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. Radiother Oncol 15 (1989) 267-274
43. Jung H., Beck-Bornholdt H.P., Svoboda V., et al. Quantification of late complications after radiation therapy. Radiother Oncol 61 (2001) 233-246
44. Ho A.Y., Atencio D.P., Peters S., et al. Genetic predictors of adverse radiotherapy effects: The Gene-PARE project. Int J Radiat Oncol Biol Phys 65 (2006) 646-655
45. Iwakawa M., Imai T., Harada Y., et al. RadGenomics project. Nippon Igaku Hoshasen Gakkai Zasshi 62 (2002) 484-489
46. Burnet N.G., Elliott R.M., Dunning A., et al. Radiosensitivity, radiogenomics and RAPPER. Clin Oncol (R Coll Radiol) 18 (2006) 525-528
47. GENEPI Homepage. www.genepi-estro.org Accessed December 13, 2007
48. Strauch K., Fimmers R., Baur M.P., et al. How to model a complex trait. 1. General considerations and suggestions. Hum Hered 55 (2003) 202-210
49. Pan W.H., Lynn K.S., Chen C.H., et al. Using endophenotypes for pathway clusters to map complex disease genes. Genet Epidemiol 30 (2006) 143-154
50. Johansen J., Bentzen S.M., Overgaard J., et al. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 40 (1996) 101-109
51. West C.M., Davidson S.E., Elyan S.A., et al. Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 51 (2001) 10-15
52. Borgmann K., Roper B., El-Awady R., et al. Indicators of late normal tissue response after radiotherapy for head and neck cancer: Fibroblasts, lymphocytes, genetics. DNA repair, and chromosome aberrations. Radiother Oncol 64 (2002) 141-152
53. Hoeller U., Borgmann K., Bonacker M., et al. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol 69 (2003) 137-144
54. Rieger K.E., Hong W.J., Tusher V.G., et al. Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. Proc Natl Acad Sci U S A 101 (2004) 6635-6640
55. Svensson J.P., Stalpers L.J., Esveldt-van Lange R.E., et al. Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity. PLoS Med 3 (2006) e422
56. Rødningen OK, Børresen-Dale AL, Alsner J, et al: Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis. Radiother Oncol (in press)
57. Alsner J., Rødningen O.K., and Overgaard J. Differential gene expression before and after ionizing radiation of subcutaneous fibroblasts identifies breast cancer patients resistant to radiation-induced fibrosis. Radiother Oncol 83 (2007) 261-266
58. Herskind C., Bentzen S.M., Overgaard J., et al. Differentiation state of skin fibroblast cultures versus risk of subcutaneous fibrosis after radiotherapy. Radiother Oncol 47 (1998) 263-269
59. Herskind C., Johansen J., Bentzen S.M., et al. Fibroblast differentiation in subcutaneous fibrosis after postmastectomy radiotherapy. Acta Oncol 39 (2000) 383-388
60. Travis E.L. Genetic susceptibility to late normal tissue injury. Semin Radiat Oncol 17 (2007) 149-155
61. Kruse J.J., and Stewart F.A. Gene expression arrays as a tool to unravel mechanisms of normal tissue radiation injury and prediction of response. World J Gastroenterol 13 (2007) 2669-2674
62. Ahn J., Ambrosone C.B., Kanetsky P.A., et al. Polymorphisms in genes related to oxidative stress (CAT. MnSOD, MPO, and eNOS) and acute toxicities from radiation therapy following lumpectomy for breast cancer. Clin Cancer Res 12 (2006) 7063-7070
63. Ambrosone C.B., Tian C., Ahn J., et al. Genetic predictors of acute toxicities related to radiation therapy following lumpectomy for breast cancer: A case-series study. Breast Cancer Res 8 (2006) R40
64. Andreassen C.N., Overgaard J., Alsner J., et al. ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 64 (2006) 776-783
65. Angele S., Romestaing P., Moullan N., et al. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 63 (2003) 8717-8725
66. Appleby J.M., Barber J.B., Levine E., et al. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 76 (1997) 1546-1549
67. Bremer M., Klopper K., Yamini P., et al. Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: No observation of increased radiation-induced acute or late effects. Radiother Oncol 69 (2003) 155-160
68. Cesaretti J.A., Stock R.G., Lehrer S., et al. ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. Int J Radiat Oncol Biol Phys 61 (2005) 196-202
69. Chang-Claude J., Popanda O., Tan X.L., et al. Association between polymorphisms in the DNA repair genes. XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res 11 (2005) 4802-4809
70. Clarke R.A., Goozee G.R., Birrell G.W., et al. Absence of ATM truncations in patients with severe acute radiation reactions. Int J Radiat Oncol Biol Phys 41 (1998) 1021-1027
71. Damaraju S., Murray D., Dufour J., et al. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res 12 (2006) 2545-2554
72. De Ruyck K., Van Eijkeren M., Claes K., et al. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: Association with single nucleotide polymorphisms in XRCC1. XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. Int J Radiat Oncol Biol Phys 62 (2005) 1140-1149
73. De Ruyck K., Wilding C.S., Van Eijkeren M., et al. Microsatellite polymorphisms in DNA repair genes XRCC1. XRCC3 and XRCC5 in patients with gynecological tumors: Association with late clinical radiosensitivity and cancer incidence. Radiat Res 164 (2005) 237-244
74. De Ruyck K., Van Eijkeren M., Claes K., et al. TGFbeta1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors. Int J Radiat Oncol Biol Phys 65 (2006) 1240-1248
75. Edvardsen H., Kristensen V.N., Grenaker Alnaes G.I., et al. Germline glutathione S-transferase variants in breast cancer: Relation to diagnosis and cutaneous long-term adverse effects after two fractionation patterns of radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1163-1171
76. Gaffney D.K., Brohet R.M., Lewis C.M., et al. Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. Radiother Oncol 47 (1998) 129-136
77. Giotopoulos G., Symonds R.P., Foweraker K., et al. The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer 96 (2007) 1001-1007
78. Green H., Ross G., Peacock J., et al. Variation in the manganese superoxide dismutase gene (SOD2) is not a major cause of radiotherapy complications in breast cancer patients. Radiother Oncol 63 (2002) 213-216
79. Hall E.J., Schiff P.B., Hanks G.E., et al. A preliminary report: Frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. Cancer J Sci Am 4 (1998) 385-389
80. Ho A.Y., Fan G., Atencio D.P., et al. Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 69 (2007) 677-684
81. Iannuzzi C.M., Atencio D.P., Green S., et al. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys 52 (2002) 606-613
82. Kornguth D.G., Garden A.S., Zheng Y., et al. Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants. Int J Radiat Oncol Biol Phys 62 (2005) 665-671
83. Leong T., Whitty J., Keilar M., et al. Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients. Int J Radiat Oncol Biol Phys 48 (2000) 959-965
84. Moullan N., Cox D.G., Angele S., et al. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 12 (2003) 1168-1174
85. Oppitz U., Bernthaler U., Schindler D., et al. Sequence analysis of the ATM gene in 20 patients with RTOG grade 3 or 4 acute and/or late tissue radiation side effects. Int J Radiat Oncol Biol Phys 44 (1999) 981-988
86. Pierce L.J., Strawderman M., Narod S.A., et al. Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. J Clin Oncol 18 (2000) 3360-3369
87. Popanda O., Tan X.L., Ambrosone C.B., et al. Genetic polymorphisms in the DNA double-strand break repair genes XRCC3. XRCC2, and NBS1 are not associated with acute side effects of radiotherapy in breast cancer patients. Cancer Epidemiol Biomarkers Prev 15 (2006) 1048-1050
88. Price E.A., Bourne S.L., Radbourne R., et al. Rare microsatellite polymorphisms in the DNA repair genes XRCC1. XRCC3 and XRCC5 associated with cancer in patients of varying radiosensitivity. Somat Cell Mol Genet 23 (1997) 237-247
89. Quarmby S., Fakhoury H., Levine E., et al. Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. Int J Radiat Biol 79 (2003) 137-143
90. Ramsay J., Birrell G., and Lavin M. Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. Radiother Oncol 47 (1998) 125-128
91. Severin D.M., Leong T., Cassidy B., et al. Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients. Int J Radiat Oncol Biol Phys 50 (2001) 1323-1331
92. Shayeghi M., Seal S., Regan J., et al. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br J Cancer 78 (1998) 922-927
93. Tan X.L., Popanda O., Ambrosone C.B., et al. Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients. Breast Cancer Res Treat 97 (2006) 255-262
94. Weissberg J.B., Huang D.D., and Swift M. Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes. Int J Radiat Oncol Biol Phys 42 (1998) 1133-1136